Jeena Sikho Lifecare Ltd · JSLL · Ayurvedic · price as of the 18 November 2026 close, updated every trading day · results updated weekly · research updated 16 November 2026
Jeena Sikho Lifecare share price today: ₹296.35 at the close on 18 November 2026, down 57.2% in a year. Jeena Sikho Lifecare (JSLL) is worth ₹3,685 crore, trades at a P/E of 15.6 and has closed between ₹296.35 and ₹748.25 over the past 52 weeks. Latest change: number of shareholders up 193% in a year.
Jeena Sikho Lifecare Ltd's earnings have grown faster than its share price. Earnings per share grew +103.1% in a year while the price moved −57.2%.
The main question: earnings per share (last four quarters) moved +103.1% while the share price moved −57.2%.
The price has been falling for 19 weeks, and the P/E is lower than 100% of its own last 4.6 years. Over the last four quarters, results have been improving, with profit +29.4% on a year earlier, and 103% of the last 3 years' profit came in as cash. What will decide it: whether the price catches up with earnings that have already grown.
What is the Jeena Sikho Lifecare share price today?
Jeena Sikho Lifecare Ltd's share price was ₹296.35 at the close on 18 November 2026. It has been falling for 19 weeks. That is 44.0% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹296 and ₹748, and at that close it was at the low of that range.
A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Jeena Sikho Lifecare Ltd is in stage 4. The phase helps read everything below.
Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 30 weeks running.
Week by week since 2022: did it beat the NIFTY 500 over the past 13 weeks?
Ahead in 148 of 232 weeks
| Week | 13-week return vs NIFTY 500 |
|---|---|
| 22 Apr 2022 | no NIFTY 500 reading |
| 29 Apr 2022 | no NIFTY 500 reading |
| 6 May 2022 | no NIFTY 500 reading |
| 13 May 2022 | no NIFTY 500 reading |
| 20 May 2022 | no NIFTY 500 reading |
| 27 May 2022 | no NIFTY 500 reading |
| 3 Jun 2022 | no NIFTY 500 reading |
| 9 Jun 2022 | no NIFTY 500 reading |
| 16 Jun 2022 | no NIFTY 500 reading |
| 24 Jun 2022 | no NIFTY 500 reading |
| 1 Jul 2022 | no NIFTY 500 reading |
| 8 Jul 2022 | no NIFTY 500 reading |
| 13 Jul 2022 | no NIFTY 500 reading |
| 22 Jul 2022 | −0.6% |
| 29 Jul 2022 | −6.2% |
| 5 Aug 2022 | −7.1% |
| 12 Aug 2022 | −5.8% |
| 19 Aug 2022 | −10.5% |
| 26 Aug 2022 | +0.7% |
| 2 Sep 2022 | +3.3% |
| 9 Sep 2022 | −1.2% |
| 15 Sep 2022 | −2.6% |
| 23 Sep 2022 | −3.2% |
| 30 Sep 2022 | +2.1% |
| 7 Oct 2022 | −4.9% |
| 14 Oct 2022 | −6.0% |
| 21 Oct 2022 | −18.5% |
| 28 Oct 2022 | −21.6% |
| 4 Nov 2022 | −15.2% |
| 11 Nov 2022 | −7.1% |
| 18 Nov 2022 | +61.8% |
| 25 Nov 2022 | +53.9% |
| 2 Dec 2022 | +63.1% |
| 9 Dec 2022 | +60.0% |
| 16 Dec 2022 | +56.4% |
| 23 Dec 2022 | +50.1% |
| 30 Dec 2022 | +44.7% |
| 6 Jan 2023 | +58.4% |
| 13 Jan 2023 | +102.1% |
| 20 Jan 2023 | +87.0% |
| 27 Jan 2023 | +110.2% |
| 3 Feb 2023 | +96.3% |
| 10 Feb 2023 | +96.6% |
| 17 Feb 2023 | +20.4% |
| 24 Feb 2023 | +12.8% |
| 3 Mar 2023 | +6.9% |
| 10 Mar 2023 | +11.0% |
| 17 Mar 2023 | +15.0% |
| 24 Mar 2023 | +25.8% |
| 31 Mar 2023 | +28.9% |
| 6 Apr 2023 | +24.4% |
| 13 Apr 2023 | +3.4% |
| 21 Apr 2023 | +12.6% |
| 28 Apr 2023 | +0.2% |
| 5 May 2023 | +4.6% |
| 12 May 2023 | +10.6% |
| 19 May 2023 | +9.2% |
| 26 May 2023 | +13.4% |
| 2 Jun 2023 | +49.4% |
| 9 Jun 2023 | +64.1% |
| 16 Jun 2023 | +55.2% |
| 23 Jun 2023 | +54.5% |
| 30 Jun 2023 | +51.3% |
| 7 Jul 2023 | +66.0% |
| 14 Jul 2023 | +91.0% |
| 21 Jul 2023 | +85.3% |
| 28 Jul 2023 | +126.4% |
| 4 Aug 2023 | +185.2% |
| 11 Aug 2023 | +183.0% |
| 18 Aug 2023 | +231.1% |
| 25 Aug 2023 | +228.0% |
| 1 Sep 2023 | +144.3% |
| 8 Sep 2023 | +112.2% |
| 15 Sep 2023 | +106.7% |
| 22 Sep 2023 | +122.0% |
| 29 Sep 2023 | +92.1% |
| 6 Oct 2023 | +98.8% |
| 13 Oct 2023 | +81.0% |
| 20 Oct 2023 | +97.6% |
| 27 Oct 2023 | +75.9% |
| 3 Nov 2023 | +54.5% |
| 12 Nov 2023 | +27.4% |
| 17 Nov 2023 | +11.5% |
| 24 Nov 2023 | +4.0% |
| 1 Dec 2023 | +5.1% |
| 8 Dec 2023 | +0.9% |
| 15 Dec 2023 | +4.3% |
| 22 Dec 2023 | −6.9% |
| 29 Dec 2023 | +1.0% |
| 5 Jan 2024 | −6.4% |
| 12 Jan 2024 | −12.1% |
| 20 Jan 2024 | −16.2% |
| 25 Jan 2024 | −21.6% |
| 2 Feb 2024 | −33.4% |
| 9 Feb 2024 | +4.7% |
| 16 Feb 2024 | +11.1% |
| 23 Feb 2024 | +15.4% |
| 2 Mar 2024 | +15.8% |
| 7 Mar 2024 | +23.5% |
| 15 Mar 2024 | +20.7% |
| 22 Mar 2024 | +27.9% |
| 28 Mar 2024 | +38.2% |
| 5 Apr 2024 | +41.9% |
| 12 Apr 2024 | +63.8% |
| 19 Apr 2024 | +55.1% |
| 26 Apr 2024 | +48.8% |
| 3 May 2024 | +58.9% |
| 10 May 2024 | +24.5% |
| 18 May 2024 | +24.0% |
| 24 May 2024 | +27.6% |
| 31 May 2024 | +24.0% |
| 7 Jun 2024 | +28.0% |
| 14 Jun 2024 | +29.4% |
| 21 Jun 2024 | +19.0% |
| 28 Jun 2024 | +16.3% |
| 5 Jul 2024 | +9.5% |
| 12 Jul 2024 | −10.9% |
| 19 Jul 2024 | −8.4% |
| 26 Jul 2024 | +2.1% |
| 2 Aug 2024 | −2.5% |
| 9 Aug 2024 | −8.0% |
| 16 Aug 2024 | +3.3% |
| 23 Aug 2024 | +9.0% |
| 30 Aug 2024 | +17.3% |
| 6 Sep 2024 | +27.7% |
| 13 Sep 2024 | +16.4% |
| 20 Sep 2024 | +24.3% |
| 27 Sep 2024 | +33.9% |
| 4 Oct 2024 | +39.8% |
| 11 Oct 2024 | +41.4% |
| 18 Oct 2024 | +45.0% |
| 25 Oct 2024 | +41.1% |
| 1 Nov 2024 | +52.1% |
| 8 Nov 2024 | +55.5% |
| 14 Nov 2024 | +40.8% |
| 22 Nov 2024 | +45.4% |
| 29 Nov 2024 | +42.0% |
| 6 Dec 2024 | +56.6% |
| 13 Dec 2024 | +73.9% |
| 20 Dec 2024 | +70.5% |
| 27 Dec 2024 | +48.0% |
| 3 Jan 2025 | +52.9% |
| 10 Jan 2025 | +49.4% |
| 17 Jan 2025 | +45.1% |
| 24 Jan 2025 | +32.7% |
| 1 Feb 2025 | +12.2% |
| 7 Feb 2025 | +18.3% |
| 14 Feb 2025 | +5.2% |
| 21 Feb 2025 | −1.2% |
| 28 Feb 2025 | −6.7% |
| 7 Mar 2025 | −12.1% |
| 13 Mar 2025 | −16.6% |
| 21 Mar 2025 | −18.3% |
| 28 Mar 2025 | +7.0% |
| 4 Apr 2025 | −3.2% |
| 11 Apr 2025 | +7.3% |
| 17 Apr 2025 | +2.5% |
| 25 Apr 2025 | +3.5% |
| 2 May 2025 | +15.4% |
| 9 May 2025 | +11.9% |
| 16 May 2025 | +13.2% |
| 23 May 2025 | +8.7% |
| 30 May 2025 | +21.2% |
| 6 Jun 2025 | +12.7% |
| 13 Jun 2025 | +15.8% |
| 20 Jun 2025 | +14.2% |
| 27 Jun 2025 | −13.5% |
| 4 Jul 2025 | +12.6% |
| 11 Jul 2025 | +9.9% |
| 18 Jul 2025 | +12.2% |
| 25 Jul 2025 | +19.0% |
| 1 Aug 2025 | +24.6% |
| 8 Aug 2025 | +22.1% |
| 14 Aug 2025 | +49.0% |
| 22 Aug 2025 | +68.6% |
| 29 Aug 2025 | +67.5% |
| 5 Sep 2025 | +74.4% |
| 12 Sep 2025 | +84.8% |
| 19 Sep 2025 | +89.3% |
| 26 Sep 2025 | +93.1% |
| 3 Oct 2025 | +51.5% |
| 10 Oct 2025 | +37.7% |
| 17 Oct 2025 | +35.2% |
| 24 Oct 2025 | +34.2% |
| 31 Oct 2025 | +30.0% |
| 7 Nov 2025 | +40.3% |
| 14 Nov 2025 | +2.4% |
| 21 Nov 2025 | −7.4% |
| 28 Nov 2025 | −6.7% |
| 5 Dec 2025 | −15.5% |
| 12 Dec 2025 | −12.4% |
| 19 Dec 2025 | −11.3% |
| 26 Dec 2025 | −16.6% |
| 2 Jan 2026 | −17.7% |
| 9 Jan 2026 | −11.8% |
| 16 Jan 2026 | −2.2% |
| 23 Jan 2026 | −2.5% |
| 1 Feb 2026 | −7.8% |
| 6 Feb 2026 | −9.9% |
| 13 Feb 2026 | +0.6% |
| 20 Feb 2026 | +1.4% |
| 27 Feb 2026 | −10.8% |
| 6 Mar 2026 | −5.9% |
| 13 Mar 2026 | −8.1% |
| 20 Mar 2026 | −6.4% |
| 27 Mar 2026 | −10.1% |
| 17 Apr 2026 | +5.7% |
| 24 Apr 2026 | −2.8% |
| 30 Apr 2026 | −2.2% |
| 8 May 2026 | +7.6% |
| 15 May 2026 | −1.5% |
| 22 May 2026 | −5.4% |
| 29 May 2026 | −9.1% |
| 4 Jun 2026 | −1.5% |
| 5 Jun 2026 | +6.5% |
| 10 Jun 2026 | −4.4% |
| 12 Jun 2026 | −0.5% |
| 17 Jun 2026 | −14.6% |
| 19 Jun 2026 | −9.5% |
| 24 Jun 2026 | −16.5% |
| 25 Jun 2026 | −7.4% |
| 1 Jul 2026 | −15.6% |
| 3 Jul 2026 | −23.8% |
| 10 Jul 2026 | −10.8% |
| 17 Jul 2026 | −16.0% |
| 24 Jul 2026 | −10.9% |
| 31 Jul 2026 | −14.5% |
| 7 Aug 2026 | −10.6% |
| 14 Aug 2026 | −14.8% |
| 21 Aug 2026 | −21.6% |
| 28 Aug 2026 | −12.4% |
| 4 Sep 2026 | −7.8% |
| 11 Sep 2026 | −10.7% |
| 18 Sep 2026 | −14.1% |
| 25 Sep 2026 | −10.5% |
| 28 Sep 2026 | −10.1% |
| 1 Oct 2026 | −12.5% |
| 9 Oct 2026 | −25.6% |
| 16 Oct 2026 | −27.2% |
| 23 Oct 2026 | −33.1% |
| 30 Oct 2026 | −36.4% |
| 6 Nov 2026 | −37.6% |
| 8 Nov 2026 | −34.4% |
| 13 Nov 2026 | −34.1% |
| 18 Nov 2026 | −44.7% |
Over the last 4.6 years the share price moved +1,402% while the NIFTY 500 moved +59%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 5 June 2026. The chart above shows the 13-week comparison for every week.
This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.
What changed at Jeena Sikho Lifecare this quarter?
Three changes stood out: number of shareholders up 193% in a year, foreign funds (FIIs) cut their stake for 4 quarters in a row and revenue up on a year earlier for 5 quarters in a row (every quarter we can compare).
Number of shareholders up 193% in a year
47,872 shareholders in the September 2026 quarter, against 16,362 a year earlier.
Foreign funds (FIIs) cut their stake for 4 quarters in a row
From 6.6% to 4.5% of the company by the September 2026 quarter.
Revenue up on a year earlier for 5 quarters in a row (every quarter we can compare)
In the June 2026 quarter revenue was ₹224 crore, +28.7% on a year earlier.
What are Jeena Sikho Lifecare's latest quarterly results?
For April to June 2026 (the quarter ended 30 June 2026), Jeena Sikho Lifecare reported revenue of ₹224 crore, up 28.7% from ₹174 crore a year earlier, and a profit of ₹66.0 crore, up 29.4% from ₹51.0 crore.
Jeena Sikho Lifecare results: April to June 2026 against a year earlier
| Measure | April to June 2026 | April to June 2025 | Change |
|---|---|---|---|
| Revenue | ₹224 crore | ₹174 crore | +28.7% |
| Profit | ₹66.0 crore | ₹51.0 crore | +29.4% |
| Earnings per share | ₹5.28 | ₹4.13 | +27.8% |
| Operating margin | 41.1% | 45.4% | −4.3 points |
The next results, for July to September 2026, were due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). This page shows them once our weekly data update has read them.
The newest call in our records is from 16 November 2026, about July to September 2026; a call about these results is not in our records yet.
From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.
What is the Jeena Sikho Lifecare share price history?
Jeena Sikho Lifecare closed at ₹296.35 on 18 November 2026, down 57.2% from ₹691.90 a year earlier (21 November 2025) and up 102.7% over three years. Its highest weekly close since April 2022 was ₹816.20 on 19 September 2025.
Jeena Sikho Lifecare share price: then and now
| When | Close | Change to 18 Nov 2026 |
|---|---|---|
| 1 week ago · 11 Nov 2026 | ₹362.50 | −18.2% |
| 1 month ago · 19 Oct 2026 | ₹369.75 | −19.9% |
| 6 months ago · 15 May 2026 | ₹639.10 | −53.6% |
| 1 year ago · 21 Nov 2025 | ₹691.90 | −57.2% |
| 3 years ago · 17 Nov 2023 | ₹146.20 | +102.7% |
| Earliest weekly close in our records · 22 Apr 2022 | ₹19.73 | +1,402.0% |
| Highest weekly close since April 2022 · 19 Sep 2025 | ₹816.20 | −63.7% |
| Lowest weekly close since April 2022 · 24 Jun 2022 | ₹15.33 | +1,833.1% |
| 52-week high (weekly close) · 8 May 2026 | ₹748.25 | −60.4% |
| 52-week low (weekly close) · 18 Nov 2026 | ₹296.35 | 0.0% |
Weekly closing prices. Each change is the move from that price to the 18 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.
245 weekly closes from 22 April 2022 to 18 November 2026.
What is the latest news on Jeena Sikho Lifecare?
18 Nov 2026: Jeena Sikho Lifecare closed at ₹296.35, down 18.2% on the week and down 19.9% on the month. 16 Nov 2026: Jeena Sikho Lifecare held its results call for July to September 2026. Management guided: FY27 sales growth 20-25% reiterated, next-year growth 25-30% planned overall.
Earlier
- 21 Sep 2026: ex-date for a dividend of ₹4.50 a share.
- Results for April to June 2026: Revenue up 28.7% and profit up 29.4% on a year earlier.
What dividend does Jeena Sikho Lifecare pay?
Jeena Sikho Lifecare paid ₹4.50 a share in regular dividends in the 12 months to 18 November 2026 (1 payment), a yield of 1.52% at the ₹296.35 close on 18 November 2026. The last was a dividend of ₹4.50 a share, ex-date 21 September 2026.
Jeena Sikho Lifecare dividends since 1 April 2021
| Ex-date | Dividend per share | Type |
|---|---|---|
| 21 Sep 2026Dividend | ₹4.50 | Dividend |
| 22 Sep 2025Dividend | ₹1.10 | Dividend |
Amounts as the company declared them on the exchange. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.
Yes. Jeena Sikho Lifecare Ltd paid out 25% of its profit as dividends in FY26, and it paid a dividend in 4 of its last 8 reported years.
From the exchange corporate-actions record, read 18 November 2026.
What did Jeena Sikho Lifecare management say on the latest results call?
On the call for July to September 2026, held on 16 November 2026, Jeena Sikho Lifecare's management guided: FY27 sales growth 20-25% reiterated, next-year growth 25-30% planned overall.
“People are placing their trust in us, and in this quarter we increased that trust, but at the cost of margins. Our task now is to convert that trust back into profit.”Manish Grover, on the call for July to September 2026
What management guided
- Q4 plus next-year operating profit 35-40% planned with only limited Q3 lift expected.
- Monthly sales ₹90-95 crore over December-March toward ₹1,000 crore year.
- Beds about 2,900 operational before March 31 on Lucknow and Ahmedabad starts; 7,000-10,000 beds in 3-5 years with turnover ₹2,000-3,000 crore.
- Ticket restoration to ₹8,200-8,400 band over next 2-3 quarters on core protocol return.
Management’s own plans and goals, from our notes of the call. A plan is not a result.
Source: the call transcript.
From the call for July to September 2026, 16 November 2026.
What to watch in Jeena Sikho Lifecare's next results?
When Jeena Sikho Lifecare reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Occupancy recovery from Diwali-week low on restored core protocols and day-care conversion - verify volume and stay mix.
Management raised each of these on the latest results call.
- Occupancy recovery from Diwali-week low on restored core protocols and day-care conversion - verify volume and stay mix.
- Ticket repair toward flagged band as preventive packages rebalanced with treatment Panchakarma - verify realization path.
- Conversion of expanded e-commerce household base into hospital Panchakarma without renewed acquisition spike - verify funnel yield.
- Portal 2.0 collections within flagged window while keeping government share within cap - verify receivables and payer mix.
Which stock lists is Jeena Sikho Lifecare on?
Jeena Sikho Lifecare is not on any of our India lists this week.
Is Jeena Sikho Lifecare profitable?
Jeena Sikho Lifecare Ltd earned ₹66.0 Cr of net profit in the Jun 2026 quarter, +29.4% on the same quarter a year earlier. That is the 5th quarter in a row of profit growth. Full-year FY26 profit was ₹222 Cr. Over 7 years profit has grown 67.5% a year on average. The same quarter a year earlier earned ₹51.0 Cr.
Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.
The Jun 2026 quarter's profit is 29.5% of that quarter's revenue.
For the full year, FY26 profit was ₹222 Cr (+177.5% on the year before).
Why profit moved: revenue changed +28.7% on a year earlier and the margin moved −4.3 percentage points. Sales did the work while the margin got thinner.
On average over the last four quarters, profit changed +160.8% and revenue +60.6%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.
How much revenue does Jeena Sikho Lifecare make, and is it growing?
Jeena Sikho Lifecare Ltd reported ₹224 Cr of revenue in the Jun 2026 quarter, +28.7% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 7 years it has grown 33.5% a year on average. The last full year, FY26, came in at ₹801 Cr.
Revenue is everything the company billed its customers in the period.
The last four reported quarters add to ₹852 Cr.
FY26 revenue was ₹801 Cr, +70.8% on the year before.
Recent pace: the last four quarters grew +60.6% on average, against 33.5% a year over the longer run, so this year is growing faster than its own long-run rate.
How much of every ₹100 of sales does Jeena Sikho Lifecare keep?
Jeena Sikho Lifecare Ltd's operating margin was 41.1% in the Jun 2026 quarter, 4.3 percentage points lower than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 8 years it has been between 10.4% and 43.8%. The latest quarter is within that range.
Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.
Why the margin moved: operating margin changed −4.2 percentage points on the year while gross margin changed −5.1 points. So the drop came mostly from the gross margin, which means input costs and prices charged.
As noted under valuation: when margins are at a record, every ratio built on profit looks better than usual, so a low multiple can mislead.
Is Jeena Sikho Lifecare's profit turning into cash?
Over the last 3 years, 103% of Jeena Sikho Lifecare Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹262 Cr of operating cash against ₹222 Cr of profit. After ₹34.0 Cr of spending on assets, ₹220 Cr was left over as free cash.
The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.
Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.
Why 103% of profit came in as cash: the cash cycle got 117 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner.
What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.
Where does Jeena Sikho Lifecare's cash go?
Jeena Sikho Lifecare Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 26 days in FY26, down from 143 days in FY21. It spent ₹92.0 Cr on assets over the last 3 years. Customers take 32 days to pay, and stock sits for 80 days on average.
Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.
At FY26 sales of ₹801 Cr, each day of that cycle ties up about ₹2.2 Cr, so roughly ₹57.0 Cr is tied up in the business at any time.
FY26: customers took 32 days to pay and stock sat for 80 days, about 2.6 months of sales sitting as stock, for a full cycle of 26 days, shorter than FY21's 143.
The full loop: cash goes out to suppliers and production on day 0. Stock sits for 80 days. Customers pay about 32 days after that. Suppliers are paid at 86 days. Together that makes the 26-day cycle.
Spending on assets: ₹92.0 Cr over the last 3 years, against ₹82.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹3.0 Cr (FY26): assets paid for that are not earning yet.
In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.
What is Jeena Sikho Lifecare's P/E ratio, and how does it compare with its own history?
Jeena Sikho Lifecare Ltd's P/E is 15.6×, about the lowest it has ever been. Its usual P/E (the middle reading) is 41.5×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.
P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.
Keep one thing in mind: margins are the best this company has ever reported. A multiple that looks low against its own past can mislead when profit is at a record. If margins fall back, today's multiple is higher than it looks.
Why the multiple is where it is: over the past year earnings per share moved +103.1% while the price moved −57.2%. Earnings did better than the price, which pulled the multiple down within its own range.
In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple.
Is the Jeena Sikho Lifecare business getting better or worse?
Jeena Sikho Lifecare Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 8 quarters of 1 measure, with some gaps.
Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.
Why it matters: with too little history, we say so rather than guess a direction.
One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.
There are fewer than eight usable quarters, so this page does not guess a direction from so little history.
Compound annual growth rate (%)
Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.
| Measure | 1yr | 3yr | 5yr | 10yr |
|---|---|---|---|---|
| Revenue | +70.8% | +57.8% | +42.6% | — |
| Profit | +177.5% | +86.9% | +85.9% | — |
| EPS | +177.9% | +87.5% | +77.0% | — |
| Share price | −57.2% | +26.6% | — | — |
How much does Jeena Sikho Lifecare earn on its capital?
Jeena Sikho Lifecare Ltd earned a ROCE of 64% in FY26. That is up from a low of 38% in FY20. Its return on capital used (ROIC) is 48.8 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 27.7% net margin and 1.19× asset turnover (sales divided by assets).
Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.
Why the return is what it is (FY26): a 27.7% net margin × 1.19× asset turnover × 1.44× leverage (assets divided by equity) ≈ 47.5% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed.
The key test, return on capital used minus the cost of capital: 60.8% − 12.0% = +48.8 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. A gap this wide means each rupee put back into the business creates more than a rupee of value.
The 60.8% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 62.9%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.
Does Jeena Sikho Lifecare have too much debt?
Jeena Sikho Lifecare Ltd has total debt of ₹127 Cr against shareholder equity of ₹468 Cr as of Mar 2026, so its debt is 0.27× its equity, which is very little. Year by year, that ratio went from 0.01 in FY23 to 0.27 in FY26. So the returns on this page come from the business, not from borrowed money.
Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.
What is the Jeena Sikho Lifecare shareholding pattern?
Promoters cut their stake in Jeena Sikho Lifecare Ltd by 4.2 percentage points over 8 quarters, the biggest change among its owners. Promoters now own 63.7% of the company. Foreign institutions moved +4.2 points over the same period, to 4.5%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.
Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.
Over the last two years: Promoters: −4.2 points over 8 quarters, to 63.7%; Foreign institutions: +4.2 points over 8 quarters, to 4.5%; Domestic institutions: +0.5 points over 8 quarters, to 0.5%.
Why the owners changed: promoters drove it (−4.2 points), with the other side taken by foreign institutions (+4.2 points). They reduced their stake.
How far is Jeena Sikho Lifecare from balance-sheet trouble?
For Jeena Sikho Lifecare Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.
The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.
How does Jeena Sikho Lifecare rank in its industry?
76.0 out of 100, rank 1 of 1 in Ayurvedic, with 82% of the evidence available.
Jeena Sikho Lifecare Ltd scores 76.0 out of 100 against the 1 companies it is compared with in Ayurvedic, ranking 1. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
The four parts add up to the total exactly: 28 + 22 + 18.5 + 7.5 = 76. This is the same number shown on the industry page; it is worked out once for the whole group and read here.
What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.
Which companies is Jeena Sikho Lifecare compared with?
Jeena Sikho Lifecare ranks 1 of 1 Ayurvedic companies on the 4-Factor Sector Score, with 76.0 out of 100.
- 1Jeena Sikho Lifecare Ltd this pageJSLL · quiet · Most evidence points up · 82% evidence76.0out of 100
How the score adds up
Growth & earnings 28.0/35 · Revenue 56.9% · Profit 100% · Operating margin change -4 points · 100% evidenceCapital efficiency 22.0/25 · ROCE 64.4% (year to Mar 2026) · Operating margin 41.1% · 100% evidenceValuation 18.5/20 · P/E 15.6× · PEG 0.39 · 85% evidenceRelative strength 7.5/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -44% · 1 year -57.2% · 25% evidence · 0 of 12 weeks aheadExact sum: 28 + 22 + 18.5 + 7.5 = 76 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.
In this ranking every company's P/E uses its own latest official close and its last four filed quarters, the same rule as the top of this page. ROCE here is each company's last full year, as labelled, so it can differ from the four-quarter ROCE above. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.
Related companies: Ayurvedic, all 1 compared on one page.
Which companies are close to Jeena Sikho Lifecare in size?
Jeena Sikho Lifecare is the only Ayurvedic company on Sector Alpha, so the companies closest to it in market value across all industries are listed: Symphony, Kalyani Steels, MPS and Rallis India.
Companies close in size in other industries
- Symphony Ltd ₹3,687 crore · Consumer Electronics
- Kalyani Steels Ltd ₹3,686 crore · Steel Products
- Jeena Sikho Lifecare Ltd ₹3,684 crore
- MPS Ltd ₹3,683 crore · E-Commerce - Platform - Utility
- Rallis India Ltd ₹3,682 crore · Pesticides/Agrochemicals
What else do people ask about Jeena Sikho Lifecare?
What is Jeena Sikho Lifecare's share price today?
Jeena Sikho Lifecare Ltd's share price is ₹296.35, −57.2% over the past year. The whole company is worth ₹3,685 Cr on the market. It is at its lowest price of the past 52 weeks (range ₹296 to ₹748), 44.0% below its 200-day average.
The price has been falling for 19 weeks (as of 18 November 2026).
What were Jeena Sikho Lifecare's latest quarterly results?
Jeena Sikho Lifecare Ltd reported revenue of ₹224 Cr and net profit of ₹66.0 Cr for the Jun 2026 quarter. Revenue rose 28.7% and profit rose 29.4% compared with a year earlier. Earnings per share were ₹5.28.
The operating margin was 41.1%, 4.3 percentage points lower than a year earlier (as of 18 November 2026).
What is Jeena Sikho Lifecare's market cap?
Jeena Sikho Lifecare Ltd's market capitalisation is ₹3,685 Cr at a share price of ₹296.35. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 18 November 2026).
How is Jeena Sikho Lifecare performing?
Jeena Sikho Lifecare Ltd's share price has been falling for 19 weeks. In its latest quarter, revenue rose 28.7% and profit rose 29.4% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 30 weeks running (as of 18 November 2026).
Will Jeena Sikho Lifecare's share price go up?
This page does not forecast Jeena Sikho Lifecare Ltd's share price. What it shows instead: the share price is ₹296.35, and it has been falling for 19 weeks. Its P/E of 15.6× is higher than 0% of its own last 5 years (as of 18 November 2026).
Who owns Jeena Sikho Lifecare?
Promoters own 63.7% of Jeena Sikho Lifecare Ltd, foreign institutions 4.5%, domestic institutions 0.5% and the public 31.3% (latest quarter). The biggest change over the last two years: Promoters cut their stake by 4.2 percentage points over 8 quarters (as of 18 November 2026).
Where is Jeena Sikho Lifecare in its business cycle?
Jeena Sikho Lifecare Ltd's FY26 operating margin was 43.8%, against a 8-year range of 10.4% to 43.8%. The latest quarter was 41.1%, the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high.
Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 18 November 2026).
What could break the Jeena Sikho Lifecare story?
The main question: earnings per share (last four quarters) moved +103.1% while the share price moved −57.2%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 18 November 2026).
Is Jeena Sikho Lifecare a stock worth studying right now?
What the numbers show: Jeena Sikho Lifecare Ltd's earnings have grown faster than its share price. Earnings per share grew +103.1% in a year while the price moved −57.2%. The main open question: whether the price catches up with earnings that have already grown.
Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 18 November 2026).
Is there a Jeena Sikho Lifecare share price forecast for 2026?
What management itself guided: FY27 sales growth 20-25% reiterated, next-year growth 25-30% planned overall.
Where do these numbers come from?
Sector Alpha, written by code from the published numbers. Data as of 18 November 2026.
Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.
See the plain-text version of this page.
More lists
Every Sector Alpha list, grouped
Stock screens
Market lists
Themes
Sectors
X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.